NASDAQ:ALNAQ

Allena Pharmaceuticals (ALNAQ) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.0001
$0.0003
50-Day Range
N/A
52-Week Range
$0.0001
$0.0185
Volume
96,558 shs
Average Volume
N/A
Market Capitalization
$12,208.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ALNAQ stock logo

About Allena Pharmaceuticals Stock (NASDAQ:ALNAQ)

Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts. On September 2, 2022, Allena Pharmaceuticals, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on May 18, 2023.

ALNAQ Stock News Headlines

See More Headlines
Receive ALNAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allena Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:ALNAQ
Web
N/A
Employees
12
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
117,566,000
Market Cap
$12,208.00
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Geoffrey A. Swire
    COO & Senior Vice President-Corporate Development
  • Hugh Wight
    Senior Vice President-Technical Operations
  • Matthew Foster
    Chief Restructuring Officer

This page (NASDAQ:ALNAQ) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners